Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe

Paola Minghetti, Doriana Pantano, Chiara Grazia Milena Gennari and Antonella Casiraghi

Health Policy, 2014, vol. 117, issue 3, 328-333

Abstract: Pharmaceutical preparations are medicines that the pharmacist makes for the special needs of the patients that the pharmaceutical industry cannot comply for economic and logistic reasons. Pharmacy compounding is still an important component of pharmacy practice and a valuable therapeutical service that is an integrant part of the modern health care system, but its legislation is not harmonized among European and US countries.

Keywords: Extemporaneous; Regulation; Resolution; Pharmacy compounding; Pharmaceutical preparations (search for similar items in EconPapers)
Date: 2014
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851014001754
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:117:y:2014:i:3:p:328-333

DOI: 10.1016/j.healthpol.2014.07.010

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().